Granalix is a startup biotechnology company founded by Prof Ruth Gabizon from the Neurology Department of the Hadassah Medical Center and Prof Shlomo Magdassi, from the Casali Institute of Chemistry of The Hebrew University.
Granagard is the results of their combined experience and knowledge in neurodegenerative diseases and nanotechnology delivery systems. The company was founded under the umbrella of Hadasit and Yissum, the technology transfer companies of Hadassah Medical Center and the Hebrew University of Jerusalem.
The Neurology Department of the Hadassah Medical Center, Jerusalem.
The Casali Institute of Applied Chemistry, Hebrew University of Jerusalem.